Should we treat children with idiopathic short stature? Workshop held in St.-Paul-de-Vence, France, April 18-19, 1999

C. J H Kelnar, K. Albertsson-Wikland, R. L. Hintz, M. B. Ranke, Ronald (Ron) Rosenfeld

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The use of growth hormone (GH) to treat short children who are clearly GH-deficient is now well accepted. However, GH treatment of short children who have no currently recognizable abnormalities in their GH-insulin-like growth factor I axis remains controversial. Whether such children with so-called idiopathic short stature (ISS) should be treated with GH was the subject of an international workshop held in St.-Paul-de-Vence, France, in April 1999. This article summarizes the issues discussed at the workshop, including the definition of ISS, ethical and health-economic aspects of treatment, results from clinical trials and surveillance studies, and the use of prediction models in aiding treatment decisions. Copyright (C) 2000 S. Karger AG, Basel.

Original languageEnglish (US)
Pages (from-to)150-157
Number of pages8
JournalHormone Research
Volume52
Issue number3
StatePublished - 1999

Fingerprint

Growth Hormone
France
Education
Insulin-Like Growth Factor I
Therapeutics
Economics
Clinical Trials
Health

Keywords

  • Growth
  • Growth hormone
  • Height, final
  • Prediction model, height
  • Quality of life
  • Short stature, idiopathic

ASJC Scopus subject areas

  • Endocrinology

Cite this

Kelnar, C. J. H., Albertsson-Wikland, K., Hintz, R. L., Ranke, M. B., & Rosenfeld, R. R. (1999). Should we treat children with idiopathic short stature? Workshop held in St.-Paul-de-Vence, France, April 18-19, 1999. Hormone Research, 52(3), 150-157.

Should we treat children with idiopathic short stature? Workshop held in St.-Paul-de-Vence, France, April 18-19, 1999. / Kelnar, C. J H; Albertsson-Wikland, K.; Hintz, R. L.; Ranke, M. B.; Rosenfeld, Ronald (Ron).

In: Hormone Research, Vol. 52, No. 3, 1999, p. 150-157.

Research output: Contribution to journalArticle

Kelnar, CJH, Albertsson-Wikland, K, Hintz, RL, Ranke, MB & Rosenfeld, RR 1999, 'Should we treat children with idiopathic short stature? Workshop held in St.-Paul-de-Vence, France, April 18-19, 1999', Hormone Research, vol. 52, no. 3, pp. 150-157.
Kelnar CJH, Albertsson-Wikland K, Hintz RL, Ranke MB, Rosenfeld RR. Should we treat children with idiopathic short stature? Workshop held in St.-Paul-de-Vence, France, April 18-19, 1999. Hormone Research. 1999;52(3):150-157.
Kelnar, C. J H ; Albertsson-Wikland, K. ; Hintz, R. L. ; Ranke, M. B. ; Rosenfeld, Ronald (Ron). / Should we treat children with idiopathic short stature? Workshop held in St.-Paul-de-Vence, France, April 18-19, 1999. In: Hormone Research. 1999 ; Vol. 52, No. 3. pp. 150-157.
@article{cae24b39da9548aba7290604687ae5b0,
title = "Should we treat children with idiopathic short stature? Workshop held in St.-Paul-de-Vence, France, April 18-19, 1999",
abstract = "The use of growth hormone (GH) to treat short children who are clearly GH-deficient is now well accepted. However, GH treatment of short children who have no currently recognizable abnormalities in their GH-insulin-like growth factor I axis remains controversial. Whether such children with so-called idiopathic short stature (ISS) should be treated with GH was the subject of an international workshop held in St.-Paul-de-Vence, France, in April 1999. This article summarizes the issues discussed at the workshop, including the definition of ISS, ethical and health-economic aspects of treatment, results from clinical trials and surveillance studies, and the use of prediction models in aiding treatment decisions. Copyright (C) 2000 S. Karger AG, Basel.",
keywords = "Growth, Growth hormone, Height, final, Prediction model, height, Quality of life, Short stature, idiopathic",
author = "Kelnar, {C. J H} and K. Albertsson-Wikland and Hintz, {R. L.} and Ranke, {M. B.} and Rosenfeld, {Ronald (Ron)}",
year = "1999",
language = "English (US)",
volume = "52",
pages = "150--157",
journal = "Hormone Research in Paediatrics",
issn = "1663-2818",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Should we treat children with idiopathic short stature? Workshop held in St.-Paul-de-Vence, France, April 18-19, 1999

AU - Kelnar, C. J H

AU - Albertsson-Wikland, K.

AU - Hintz, R. L.

AU - Ranke, M. B.

AU - Rosenfeld, Ronald (Ron)

PY - 1999

Y1 - 1999

N2 - The use of growth hormone (GH) to treat short children who are clearly GH-deficient is now well accepted. However, GH treatment of short children who have no currently recognizable abnormalities in their GH-insulin-like growth factor I axis remains controversial. Whether such children with so-called idiopathic short stature (ISS) should be treated with GH was the subject of an international workshop held in St.-Paul-de-Vence, France, in April 1999. This article summarizes the issues discussed at the workshop, including the definition of ISS, ethical and health-economic aspects of treatment, results from clinical trials and surveillance studies, and the use of prediction models in aiding treatment decisions. Copyright (C) 2000 S. Karger AG, Basel.

AB - The use of growth hormone (GH) to treat short children who are clearly GH-deficient is now well accepted. However, GH treatment of short children who have no currently recognizable abnormalities in their GH-insulin-like growth factor I axis remains controversial. Whether such children with so-called idiopathic short stature (ISS) should be treated with GH was the subject of an international workshop held in St.-Paul-de-Vence, France, in April 1999. This article summarizes the issues discussed at the workshop, including the definition of ISS, ethical and health-economic aspects of treatment, results from clinical trials and surveillance studies, and the use of prediction models in aiding treatment decisions. Copyright (C) 2000 S. Karger AG, Basel.

KW - Growth

KW - Growth hormone

KW - Height, final

KW - Prediction model, height

KW - Quality of life

KW - Short stature, idiopathic

UR - http://www.scopus.com/inward/record.url?scp=0033501811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033501811&partnerID=8YFLogxK

M3 - Article

C2 - 10725780

AN - SCOPUS:0033501811

VL - 52

SP - 150

EP - 157

JO - Hormone Research in Paediatrics

JF - Hormone Research in Paediatrics

SN - 1663-2818

IS - 3

ER -